CQENS extends Series A and B warrants.
CQENS Technologies Inc. extended the exercise periods for Series A and B common stock purchase warrants to commence September 30, 2029, and expire September 30, 2032. The extension…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
CQENS Technologies Inc. extended the exercise periods for Series A and B common stock purchase warrants to commence September 30, 2029, and expire September 30, 2032. The extension…
Fly-E Group received a deficiency letter from Nasdaq regarding a delayed Q2 Form 10-Q, which the company filed and rectified on September 3, 2026, preventing immediate delisting.
Kesselman & Kesselman CPA agreed to incorporate past audit reports into potential future SEC registrations for Teva, with a specific exception for its September 2026 segment change…
The FDA issued Emergency Use Authorization for Capstar tablets and its generic version to treat New World Screwworm in dogs and cats.
The U.S. Food and Drug Administration has issued a request for information to gather public input on advancing the development of botanical drug products.
BMO 2026-5C16 Mortgage Trust filed a current report on Form 8-K with the SEC dated August 28, 2026.
Summit partner Akeso announced positive overall survival results from the Phase III HARMONi-2 trial in NSCLC. Ivonescimab, licensed for Summit's territories as SMT112, showed stati…
FARADAY FUTURE AI-Robotics AIBOT INC. PDF 99-1 AMENDED SERVICES SCOPE ADDS TIMELINES U.S. COMPLIANCE DELIVERABLES
Aptevo Therapeutics reported a 93% clinical benefit rate in evaluable TP53-mutated AML patients treated with its mipletamig triplet, nearly double published venetoclax outcomes, sh…
On September 2, 2026, CXApp confirmed it regained compliance with Nasdaq listing requirements after the company's stock closed at or above $1.00 for the last 10 consecutive busines…
Climb Bio reported Phase 1 data for anti-APRIL antibody CLYM116 demonstrating a ~29-day half-life and >90% APRIL suppression, supporting every-12-week dosing. The company expects i…
JATT III Acquisition Corp filed an 8-K including audited financial statements and an independent auditor's report as of August 27, 2026.
Anavex Life Sciences has filed its quarterly reports for Q2 and Q3 2026, bringing the company back into full compliance with Nasdaq listing standards pending the ticker's reinstate…
Reborn Coffee, Inc. received a notice from Nasdaq stating the company no longer complies with listing requirements due to its failure to file the Form 10-Q for the period ended Jun…
Cal-Maine Foods Inc. entered into a Second Amended and Restated Credit Agreement, replacing an existing agreement and tying future borrowing costs to the Secured Overnight Financin…
Pentair plc amended its credit agreement dated September 1, 2026. The modification establishes two new Term Loan facilities with published CUSIP numbers, replacing prior terms.
Nerdy has regained compliance with NYSE Listing Standards, confirming its minimum share price threshold was met as of August 31, 2026. The company's stock remains listed on the NYS…
SLM Student Loan Trust 2003-1 published an exhibit detailing the characteristics and selected data for its student loan pool. The report covers the selection criteria for the origi…
Riverview Bancorp, Inc. has filed updated bylaws with the SEC. The filing outlines governance procedures for shareholder meetings and corporate operations, including the election o…
The BBCMS Mortgage Trust 2019-C4 filed an 8-K report(date unclear) with the SEC, no specific financial events detailed in the text.